Company
Metagenomi ($MGX)
Overview
Develops in vivo genome-editing systems derived from metagenomics to create genetic medicines intended to correct disease-causing mutations in the human genome.
Company
Develops in vivo genome-editing systems derived from metagenomics to create genetic medicines intended to correct disease-causing mutations in the human genome.